NASDAQ: TFFP
NASDAQ: OTLK
Lawrence A. Kenyon
President, Chief Executive Officer and Chief Financial Officer
Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab (LYTENAVA™ or bevacizumab-vikg), for use in retinal indications, including wet AMD, DME and BRVO.
11:00am ET
NASDAQ: COCP
Gary Wilcox, Ph.D.
Chairman of the Board and Chief Executive Officer
Cocrystal is a biotechnology company discovering & developing novel antiviral therapeutics that target the replication machinery of influenza virus, hepatitis C virus, noroviruses & coronaviruses through utilizing its structure-based technologies.
11:30am ET
NASDAQ: XBIO
Jeffrey F. Eisenberg
Chief Executive Officer
Xenetic is a biopharmaceutical company focused on progressing XCART™, a personalized CAR T platform technology engineered to target patient- & tumor-specific neoantigens, initially being advanced for the treatment of B-cell lymphomas.
1:00pm ET
TSX-V: CZO;
OTCQX: CRPOF
Gilles Gagnon, M.Sc., MBA
President and Chief Executive Officer
Ceapro Inc. is a biotechnology company involved in the development & commercialization of “active ingredients” derived from oats & other renewable plant resources for healthcare and cosmetic industries utilizing its proprietary extraction technology.
1:30pm ET

NASDAQ: GHSI
Michael Favish
Chief Executive Officer, President and Director
Guardion is a specialty health sciences company (i) that has developed medical foods & medical devices in the ocular health marketplace & (ii) that is developing nutraceuticals that it believes will provide medicinal
and health benefits to consumers.
2:00pm ET
NASDAQ: AREC
Mark C. Jensen
Chief Executive Officer and Chairman of Board
American Resources is a supplier of high-quality raw materials to the rapidly growing global infrastructure market. The Company is focused on the extraction
and processing of metallurgical carbon, an essential ingredient used in steelmaking.
2:30pm ET
PRIVATE COMPANY
Andrew Fox
Chief Executive Officer, Co-Founder
Charge is a micromobility company dedicated to building the largest network of electric charging, storage and service stations for e-scooters and e-bikes.
© 2020 Virtual Investor Summit All rights reserved.
10:00am ET
Glenn Mattes
President, Chief Executive Officer and Director
TFF Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology, which can improve the absorption of poorly water-soluble drugs.